⌘K
Loading ticker…
Mannkind Corporation · Healthcare · Pharmaceutical Products
As of 2026-06-26, Mannkind Corporation (MNKD) has a 3-month relative strength percentile of 94 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.1%, relative volume 2.07×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 94, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
MNKD is held by 6 ETFs as of Mar 2026. Top owner: XBI at 0.36% weight, $27M notional. Top 3 carry $67M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.36% | $27M |
| VTIVanguard Total Stock Market ETF | 0.00% | $22M |
| IWMiShares Russell 2000 ETF | 0.03% | $18M |
| VXFVanguard Extended Market ETF | 0.01% | $8M |
| IWOiShares Russell 2000 Growth ETF | 0.05% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MNKD Jan avg: -3.12% median: -3.15% win: 50% σ: 6.98% n: 4 2022-04-12 → 2026-05-29 | MNKD Feb avg: -7.86% median: -5.62% win: 25% σ: 27.25% n: 4 2022-04-12 → 2026-05-29 | MNKD Mar avg: -10.81% median: -14.08% win: 25% σ: 16.44% n: 4 2022-04-12 → 2026-05-29 | MNKD Apr avg: -2.50% median: -6.10% win: 40% σ: 11.14% n: 5 2022-04-12 → 2026-05-29 | MNKD May avg: 16.65% median: 20.52% win: 80% σ: 20.98% n: 5 2022-04-12 → 2026-05-29 | MNKD Jun avg: -4.81% median: -9.37% win: 25% σ: 11.15% n: 4 2022-04-12 → 2026-05-29 (current) | MNKD Jul avg: 3.56% median: 5.71% win: 75% σ: 9.96% n: 4 2022-04-12 → 2026-05-29 | MNKD Aug avg: 9.20% median: 7.24% win: 100% σ: 8.77% n: 4 2022-04-12 → 2026-05-29 | MNKD Sep avg: -2.07% median: -4.97% win: 50% σ: 14.33% n: 4 2022-04-12 → 2026-05-29 | MNKD Oct avg: 7.44% median: 6.74% win: 100% σ: 4.17% n: 4 2022-04-12 → 2026-05-29 | MNKD Nov avg: 3.61% median: -4.20% win: 25% σ: 23.85% n: 4 2022-04-12 → 2026-05-29 | MNKD Dec avg: 3.50% median: 3.27% win: 75% σ: 7.59% n: 4 2022-04-12 → 2026-05-29 |